Medicine & Life Sciences
Randomized Controlled Trials
100%
Cost-Benefit Analysis
99%
Menorrhagia
85%
Pelvic Pain
70%
Levonorgestrel
70%
Chronic Pain
56%
Spontaneous Abortion
51%
Placebos
45%
Oximetry
44%
Congenital Heart Defects
43%
Uterine Myomectomy
40%
Hysterectomy
39%
Uterine Hemorrhage
38%
Uterine Artery Embolization
37%
Endometrial Ablation Techniques
35%
Costs and Cost Analysis
35%
Confidence Intervals
34%
Quality-Adjusted Life Years
33%
Therapeutics
32%
Pregnancy
32%
Tubal Pregnancy
31%
Leiomyoma
31%
Polyps
30%
Urinary Tract
30%
Overactive Urinary Bladder
29%
Newborn Infant
28%
Gefitinib
28%
Pelvic Infection
27%
Random Allocation
27%
Urodynamics
26%
Ectopic Pregnancy
26%
Meta-Analysis
26%
Quality of Life
25%
Urinary Bladder
25%
Conservative Treatment
25%
Pain
24%
Hemorrhage
24%
Inpatients
24%
Systematic Reviews
24%
Progesterone
22%
Methotrexate
21%
Live Birth
20%
Multicenter Studies
19%
Gabapentin
18%
Cervical Cerclage
18%
Thyroxine
17%
Outpatients
16%
Iodide Peroxidase
16%
Thoracotomy
15%
Primary Health Care
15%
Social Sciences
pain
23%
costs
22%
confidence
18%
pregnancy
16%
evaluation
15%
life years
13%
treatment effectiveness
10%
inpatient treatment
10%
technology assessment
10%
diagnostic
10%
baby
9%
economics
7%
cause
7%
physician's care
7%
health
6%
infant
6%
seizure
5%
monitoring
5%
quality of life
5%
Health Economics
5%
drug
5%